substance-use-disorder

Documents about substance-use-disorder

• Identifying Substance Use Consequences#912247ClinicalTrials.gov
• Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders#1382889ClinicalTrials.gov
• Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder#1338973ClinicalTrials.gov
• tAN for Substance Use Disorder#1030285ClinicalTrials.gov
• Role of Pavlovian Mechanisms for Control Over Substance Use#1047316ClinicalTrials.gov
• Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders#1409950ClinicalTrials.gov
• tDCS and Impulsivity#1496688ClinicalTrials.gov
• Integrative Couple Treatment for Gambling/Substance Use Disorder#1410157ClinicalTrials.gov
• Neuromodulation in Substance Use Disorders#1047388ClinicalTrials.gov
• Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder#916197ClinicalTrials.gov
• How Avatar Can Enhance Autobiographical Memory of Patients With Substance Use Disorder#1422185ClinicalTrials.gov
• The ENHANCE Project Toolkit#1398438ClinicalTrials.gov
• Behavioral Rigidity in Residential Treatment for Substance Use Disorder (RIG-TD)#1464722ClinicalTrials.gov
• The STop UNhealthy Substance Use Now Trial#1104059ClinicalTrials.gov
• Emergency Department-Substance Use Screening, Motivational Interviewing and Active Referral Targeting Substance Use Disorder and Overdose Prevention#1440137ClinicalTrials.gov
• Senyo Health With Substance Use Disorder (SUD) in Primary Care#1429577ClinicalTrials.gov
• Preventing OUD in Justice-Involved Youth#893907ClinicalTrials.gov
• Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)#914813ClinicalTrials.gov
• Mindfulness-Based Psychoeducation With Substance Use and Anxiety Disorders#1372250ClinicalTrials.gov
• Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders#878643ClinicalTrials.gov
• Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.#1350486ClinicalTrials.gov
• Substance Use Disorder Outcomes and Treatment by Autism Status in Medicaid Enrollees With Substance Use Disorder.#455446NCBI PubMed Central
• Adapted RPM-08 for Substance Use Disorder in Pakistan#1295255ClinicalTrials.gov
• Supervision in Substance Use Disorder Treatment Programs#1322027ClinicalTrials.gov
• Reentry Assist (R-Assist)#869709ClinicalTrials.gov
• Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)#1430902ClinicalTrials.gov
• Initiating Substance Use Disorder Treatment for Hospitalized Alcohol Use Disorder Patients#1451930ClinicalTrials.gov
• Home Based Treatment for Drug Use in Early Adolescents#1376432ClinicalTrials.gov
• Practice Considerations For The Anesthesia Practitioner For Methamphetamine Substance Use Disorder Patients#167479EliScholar
• Mindfulness and Acceptance Group Therapy for Substance Use#1214416ClinicalTrials.gov
• Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility#841073ClinicalTrials.gov
• Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation#834831ClinicalTrials.gov
• Maternal Brain Imaging in Opioid Use Disorder#1161493ClinicalTrials.gov
• A Digital Smoking Cessation Intervention for Adults With Substance Use Disorder#1245199ClinicalTrials.gov
• Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone#887551ClinicalTrials.gov
• Psilocybin for Methamphetamine Use Disorder#1195425ClinicalTrials.gov
• Integrated Treatment for Posttraumatic Stress Disorder and Substance Abuse in Young Adults#1138162ClinicalTrials.gov
• Emotional Regulation in People With Co-occurring Posttraumatic Stress Disorder and Substance Use Disorder#1102960ClinicalTrials.gov
• Recovery Works - Facilitating Sustainable Recovery Through Workforce#1163798ClinicalTrials.gov
• The Effect of Cognitive Behavioral Model-Based Psychoeducation on Social Exclusion, Hopelessness, and Relapse Levels in Individuals Diagnosed With Substance Use Disorder#881228ClinicalTrials.gov
• EMA for Predicting Treatment Outcomes in Patients With SUD#1260367ClinicalTrials.gov
• EMS-Initiated Buprenorphine#866715ClinicalTrials.gov
• Orexin s Role in the Neurobiology of Substance Use Disorder#1477627ClinicalTrials.gov
• Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care#980205ClinicalTrials.gov
• Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients#1475509ClinicalTrials.gov
• Computerized adaptive testing for assessing substance use and substance use disorder: A systematic review.#232383NCBI PubMed Central
• Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder#903676ClinicalTrials.gov
• Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder#898026ClinicalTrials.gov
• Incentives to Decrease Opioid Use - Pilot#850407ClinicalTrials.gov
• Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START#805563ClinicalTrials.gov